Melody Cobleigh to Matrix Metalloproteinase Inhibitors
This is a "connection" page, showing publications Melody Cobleigh has written about Matrix Metalloproteinase Inhibitors.
Connection Strength
0.072
-
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer. Clin Cancer Res. 2004 Mar 15; 10(6):1971-5.
Score: 0.059
-
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer. Ann Oncol. 2002 Aug; 13(8):1220-4.
Score: 0.013